Author

Bjorn Klem

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 1

Frequent Co-Authors

B. BolstadiD· 2 shared Pål RongvediD· 2 shared Carina Sofia Silva MatiasiD· 1 shared Carina Vingsbo LundbergiD· 1 shared Hanne Cecilie Winther-LarseniD· 1 shared Jon Ulf HanseniD· 1 shared Klaus Skovbo Jensen· 1 shared Ole Andreas ØkstadiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

9 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

B. BolstadORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

In vitro activity of combination formulations of the novel metallo-β-lactamase (MBL) inhibitor APC148 with comparator treatments against 176 MBL-containing Enterobacterales isolates from the SENTRY Antimicrobial Surveillance Program (2019-2022)

Veronika Smith, Bjorn Klem, B. Bolstad, Hanne Cecilie Winther-Larsen, Ole Andreas Økstad, Pål Rongved

This study evaluates the in vitro activity of APC148 combined with carbapenems against MBL-producing Enterobacterales isolates, showing high susceptibility rates.

bioRxiv · Mar 15, 2026 · PreprintMicrobiology

In-vitro and in-vivo efficacy of a novel broad spectrum β-lactamase inhibitor APC24-7 against Enterobacterales

Carina Sofia Silva Matias, Klaus Skovbo Jensen, B. Bolstad, Bjorn Klem, Pål Rongved, Carina Vingsbo Lundberg, Jon Ulf Hansen

This study evaluates APC24-7, a novel β-lactamase inhibitor, showing it restores meropenem activity against CRE in vitro and in vivo.

bioRxiv · Mar 6, 2026 · PreprintMicrobiology